Related Experiment Videos

A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor

M Zubiaur1, L W Forman, L L Stice

  • 1Cancer Research Center, Boston University School of Medicine, MA 02118, USA.

Oncogene
|March 21, 1996
PubMed

Insights

Activated Ras genes block Platelet-Derived Growth Factor (PDGF) receptor signaling. A membrane factor co-purifying with Ras protein inhibits PDGF receptor autophosphorylation, suggesting Ras directly or indirectly controls receptor activity.

Area of Science:

  • Cellular signaling pathways
  • Receptor tyrosine kinases
  • Ras GTPases

Background:

  • Ligand-stimulated Platelet-Derived Growth Factor (PDGF) type-beta receptor autophosphorylation is crucial for cellular responses.
  • Activated Ras genes are known to interfere with PDGF receptor signaling pathways.

Purpose of the Study:

  • To investigate the mechanism by which activated Ras genes inhibit PDGF type-beta receptor autophosphorylation.
  • To identify the inhibitory factor present in Ras-expressing cells.

Main Methods:

  • Cell membrane fractionation and protein purification using ion exchange chromatography.
  • Assays for PDGF type-beta receptor kinase activity.
  • Western blotting and immunoprecipitation with specific antibodies, including p21 ras-specific monoclonal antibodies.

Main Results:

  • A dominant inhibitor of PDGF type-beta receptor autophosphorylation was identified in membrane fractions of v-ras-expressing fibroblasts.
  • The inhibitor co-purified with activated p21 ras, Syp/PTP-2, and Grb2.
  • Neutralization of p21 ras protein abolished the inhibitory effect, restoring PDGF type-beta receptor autophosphorylation.

Conclusions:

  • Activated p21 ras plays a critical role in inhibiting PDGF type-beta receptor autokinase activity.
  • Activated Ras may directly interact with the PDGF type-beta receptor or form complexes with other signaling molecules (Syp, Grb2) to mediate inhibition.

Related Concept Videos